Specifically, analysis of 45 cases of clinical ESCC samples showed that stromal CCL22 exhibited positive relation to intratumoral expression of pGli1 Ser112/Thr115/Ser116 (Figure S14D). This evidence concerns the gene CCL22 and esophageal squamous cell carcinoma.